(Q35885085)

10 August 2017

1 reference

title

Nephrotoxic effects of X-ray contrast media (English)

1 reference

10 August 2017

Erik Andrew

1

1 reference

10 August 2017

Knut J Berg

series ordinal

2

1 reference

10 August 2017

publication date

1 January 2004

1 reference

Journal of Toxicology: Clinical Toxicology

10 August 2017

published in

1 reference

10 August 2017

volume

42

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

325-332

1 reference

Hospital-acquired renal insufficiency: a prospective study

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Hypoxia of the renal medulla--its implications for disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Nephrotoxicity related to contrast media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Nephrotoxic effects in high-risk patients undergoing angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Multiple myeloma and contrast media

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Potential deleterious effect of furosemide in radiocontrast nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

N-acetylcysteine ameliorates renal microcirculation: studies in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Acetylcysteine and contrast agent-associated nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120037430

21 January 2018

Identifiers

DOI

10.1081/CLT-120037430

1 reference

release_4ucpdvrtrjdefbq744lvbj5oim

10 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4ucpdvrtrjdefbq744lvbj5oim

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference